---
$id: https://graph.org.ai/products/commodity/51271630
$type: Product
source: UNSPSC
code: "51271630"
title: "Lidocaine hydrochloride anhydrous"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lidocaine hydrochloride anhydrous

**UNSPSC Code**: 51271630
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cation channel blocker and anesthetic agent with the molecular formula C14H22N2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EC2CNF7XFP, chemically known as acetamide, 2-(diethylamino)-n-(2,6-dimethylphenyl)-, monohydrochloride, but more generally known as lidocaine hydrochloride anhydrous, which bears US NIH Compound Identifier 6314. European Medicines Agency schedules lidocaine hydrochloride anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08507MIG. Most nations, for tariff purposes, schedule lidocaine hydrochloride anhydrous under HS 29242910. Lidocaine hydrochloride anhydrous bears US NLM identifiers UMLS ID C2756728 and NCI Concept Code C90650. SMILES: CCN(CC)CC(=O)NC1C(CCCC1C)C.CL.

